Skip to main content
. 2017 Jun 30;14(1):107–114. doi: 10.5114/aoms.2017.68696

Table V.

Differences between relapsing and non-relapsing patients of inactive UC group regarding activity of the disease and used treatment

Parameter Relapsing group (n = 7) Non-relapsing group (n = 11) P-value
Clinical activity (Truelove-Witts index) 1 (0–3) 1 (0–2) 0.83
Endoscopic activity (Mayo score) 2 (1–3) 1 (1–2) 0.36
Histopathological activity (Gupta score) 2 (1–3) 1 (1–2) 0.45
Disease location:
 Left-sided 15% 9% 0.43
 Pancolitis 85% 91% 0.78
Disease duration [years] 1.3 (0.5–2) 1.6 (0.8–2) 0.82
Nutritional status:
 BMI z-score –0.2 (–0.6 – 0.4) –0.4 (–0.7 – 0.2) 0.52
 Cole index 87% (82–98%) 85% (81–93%) 0.58
Treatment:
 5-ASA 15% 30% 0.73
 5-ASA and thiopurines 85% 70% 0.81

Data are presented as median values and ranges. BMI – body mass index, 5-ASA – 5 aminosalicylic acid.